Lung Cancer Drug
-
{
- All
- News
-
Lung Cancer Pill Significantly Lowers The Risk Of Death After Surgery: Study
Impressive outcomes from a lung cancer drug have been reported in recently published research over the weekend.
-
Glenmark, US-Based Particle Sciences To Develop Generic Cancer Drug
Glenmark Pharmaceuticals on Monday said it has entered into an agreement with US-based Particle Sciences Inc to develop and market a generic version of Celgene's ABRAXANE, which is used in treatments of breast and lung cancers.
-
Cadila launches lung cancer drug at Rs 40,000 per course
Homegrown drug maker Cadila Pharmaceuticals on Thursday launched a new lung cancer drug, Mycidac-C, priced at Rs 40,000 for a 10-course injection, about a tenth of the cost of those made by multinational competitors.
-
Lung Cancer Pill Significantly Lowers The Risk Of Death After Surgery: Study
Impressive outcomes from a lung cancer drug have been reported in recently published research over the weekend.
-
Glenmark, US-Based Particle Sciences To Develop Generic Cancer Drug
Glenmark Pharmaceuticals on Monday said it has entered into an agreement with US-based Particle Sciences Inc to develop and market a generic version of Celgene's ABRAXANE, which is used in treatments of breast and lung cancers.
-
Cadila launches lung cancer drug at Rs 40,000 per course
Homegrown drug maker Cadila Pharmaceuticals on Thursday launched a new lung cancer drug, Mycidac-C, priced at Rs 40,000 for a 10-course injection, about a tenth of the cost of those made by multinational competitors.
